Healthpeak Properties (PEAK) Stock Forecast & Price Target

Notice: This company has been marked as potentially delisted and may not be actively trading.

Healthpeak Properties - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 6 Analyst Ratings

Based on 6 Wall Street analysts who have issued ratings for Healthpeak Properties in the last 12 months, the stock has a consensus rating of "Hold." Out of the 6 analysts, 1 has given a sell rating, 4 have given a hold rating, and 1 has given a buy rating for PEAK.

Consensus Price Target

$20.08

High Forecast	$22.00
Average Forecast	$20.08
Low Forecast	$17.50

According to the 6 analysts' twelve-month price targets for Healthpeak Properties, the average price target is $20.08. The highest price target for PEAK is $22.00, while the lowest price target for PEAK is $17.50. .

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Hold	Hold	Hold	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	5 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$20.08	$21.79	$22.81	$26.73
Forecasted Upside	N/A	19.29% Upside	23.32% Upside	17.73% Upside

Get Healthpeak Properties Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for PEAK and its competitors with MarketBeat's FREE daily newsletter.

Ad Darwin

Top Stock Unveiled!

Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

Get Your Free Report

PEAK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

PEAK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Healthpeak Properties Stock vs. The Competition

Type	Healthpeak Properties	Finance Companies	S&P 500
Consensus Rating Score	2.00	2.45	2.50
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside		35.51% Upside	9.09% Upside
News Sentiment Rating	Neutral News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
3/4/2024	Scotiabank 5 of 5 stars	Lower Target	Sector Outperform ➝ Sector Outperform	$23.00 ➝ $22.00	+28.65%
2/12/2024	BNP Paribas 3 of 5 stars	Upgrade	Underperform ➝ Neutral	$19.00	+9.57%
1/30/2024	Deutsche Bank Aktiengesellschaft 2 of 5 stars	Initiated Coverage	Hold	$21.00	+9.26%
11/13/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Neutral ➝ Underperform	$17.50	+11.68%
10/31/2023	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$19.00	+18.90%
9/7/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$25.00 ➝ $22.00	+7.79%
Get the Latest News and Ratings for PEAK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Healthpeak Properties and its competitors with MarketBeat's FREE daily newsletter.
7/25/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight	$33.00 ➝ $32.00	+44.67%
4/28/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		$34.00 ➝ $30.00	+37.68%
4/24/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$29.00 ➝ $25.00	+18.32%
4/19/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight	$23.00	+7.63%
4/5/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$23.00	+7.08%
1/2/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$23.00 ➝ $29.00	+15.68%
12/14/2022	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Sector Perform	$35.00 ➝ $28.00	+9.25%
11/21/2022	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	In-Line ➝ Outperform	$28.00	+13.59%
9/28/2022	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Peer Perform ➝ Outperform	$27.00	+18.42%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:57 AM ET.

PEAK Forecast - Frequently Asked Questions

What is Healthpeak Properties' forecast for 2024?: According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Healthpeak Properties is $20.08, with a high forecast of $22.00 and a low forecast of $17.50.
Should I buy or sell Healthpeak Properties stock right now?: 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthpeak Properties in the last twelve months. There is currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" PEAK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PEAK, but not buy additional shares or sell existing shares.
Does Healthpeak Properties's stock price have much upside?: According to analysts, Healthpeak Properties's stock has a predicted upside of 13.98% based on their 12-month stock forecasts.
Do Wall Street analysts like Healthpeak Properties more than its competitors?: Analysts like Healthpeak Properties less than other "finance" companies. The consensus rating score for Healthpeak Properties is 2.00 while the average consensus rating score for "finance" companies is 2.45. Learn more on how PEAK compares to other companies.